Free Trial
TSE:AUP

Aurinia Pharmaceuticals (AUP) Stock Price, News & Analysis

Aurinia Pharmaceuticals logo

About Aurinia Pharmaceuticals Stock (TSE:AUP)

Advanced Chart

Key Stats

Today's Range
N/A
50-Day Range
N/A
52-Week Range
N/A
Volume
4.61 million shs
Average Volume
229,895 shs
Market Capitalization
C$2.15 billion
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Aurinia Pharmaceuticals Inc., a biopharmaceutical company, develops and commercializes therapies to treat various diseases with unmet medical need in Japan and China. The company offers LUPKYNIS for the treatment of adult patients with active lupus nephritis. It has a collaboration and license agreement with Otsuka Pharmaceutical Co., Ltd. The company is headquartered in Victoria, Canada.

Receive AUP Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Aurinia Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter.

AUP Stock News Headlines

Musk's warning signal: Prepare before the cascade begins
When Elon Musk triggered his AI layoff plan, most analysts missed what it really meant. Louis Navellier didn’t. With 40+ years of market modeling, he says Musk’s move wasn’t about efficiency — it was a signal. And what’s coming next could divide the market into winners and losers faster than anyone expects. Watch this urgent video briefing now.
See More Headlines

AUP Stock Analysis - Frequently Asked Questions

Shares of AUP stock and other Canadian stocks can be purchased through an online brokerage account. Popular online brokerages with access to the Canadian stock market include BMO InvestorLine, CIBC Investor's Edge, Desjardins Online Brokerage, HSBC InvestDirect, Laurentian Bank Discount Brokerage, National Bank Direct Brokerage, Qtrade Investor, Questrade, RBC Direct Investing, Scotia iTrade, TD Direct Investing, and Virtual Brokers.

Based on aggregate information from My MarketBeat watchlists, some other companies that Aurinia Pharmaceuticals investors own include Aurinia Pharmaceuticals (AUPH), Allena Pharmaceuticals (ALNA), Actinium Pharmaceuticals (ATNM), Neovasc (NVCN), NVIDIA (NVDA), Aurora Cannabis (ACB) and Aphria (APHA).

Industry, Sector and Symbol

Stock Exchange
TSE
Industry
Technical & System Software
Sub-Industry
Pharmaceutical Products
Current Symbol
TSE:AUP
Previous Symbol
TSE:ISA
CIK
N/A
Fax
N/A
Employees
300
Year Founded
N/A

Profitability

Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
C$57.59 million
Price / Cash Flow
6.75
Book Value
C$2.59 per share
Price / Book
N/A

Miscellaneous

Free Float
N/A
Market Cap
C$2.15 billion
Optionable
Not Optionable
Beta
N/A
 The Best Nuclear Energy Stocks to Buy Cover

Nuclear energy stocks are roaring. It's the hottest energy sector of the year. Cameco Corp, Paladin Energy, and BWX Technologies were all up more than 40% in 2024. The biggest market moves could still be ahead of us, and there are seven nuclear energy stocks that could rise much higher in the next several months. To unlock these tickers, enter your email address below.

Get This Free Report

This page (TSE:AUP) was last updated on 5/3/2025 by MarketBeat.com Staff
From Our Partners